Tozaro
The company develops synthetic affinity ligands using molecular modeling, machine learning, and chemical synthesis to improve cell and gene therapy manufacturing. These 'Smart Polymers' are designed to replace biological ligands for viral vector purification and analytics, offering animal-component-free production and scalable bioprocessing. The technology is used to achieve higher yields of functional virus and rapid virus quantification for biopharmaceutical developers.
Visit websiteLondon, UK
Healthtech
Biotechnology
Life Sciences
Funding summary
- Total raised
- €6.9M
- Funding rounds
- 1
Investors in Tozaro
Investors on record for Tozaro. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Tozaro?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors